Company profile
Winston Pharmaceuticals, Inc.
OTC: WPHM · Healthcare · Medical - Pharmaceuticals
PublicHQ Vernon Hills, Reports USD
#840 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 16
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), balance-sheet leverage · ↓ Piotroski F, return on equity
Methodology →Revenue TTM
$1.4M
Rev growth YoY (TTM)
+98.0%
Net income (FY)
-$2.7M
Employees
9
as of 2026-08-30
Market cap
$7.7k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.4M$1.4M2009
Net income-$2.7M-$2.7M2009
Operating income-$2.7M-$2.7M2009
Total assets$1.7M$1.7M2009
Liabilities$1.2M$1.2M2009
Equity$488.6k$488.6k2009
Revenue trend
FY2005 – FY2009 · USD
FY05
FY06
FY07
FY08
FY09
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Winston Pharmaceuticals, Inc.’s revenue?
Winston Pharmaceuticals, Inc. booked $1.4M in FY2009 revenue, growing 208% year over year — faster than most Healthcare companies we track, at a -190.4% net margin.
Peers · Healthcare
Braxia Scientific Corp.——Outlook Therapeutics, Inc.22DAvenue Therapeutics, Inc.25DVasamed, Inc.——Northwest Biotherapeutics, Inc.40DAffymax, Inc.——Key facts
CEOJoel E. Bernstein
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersVernon Hills, null
ExchangeOTC: WPHM
Employees9
IPO date2023-06-05
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.